NCT06734871View on ClinicalTrials.gov

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

PHASE1RecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

October 13, 2025

Study Completion Date

July 13, 2026

Conditions

B-Cell Non-Hodgkin Lymphoma

Interventions

DRUG

CAR T cells

chimeric antigen receptor T cells

Trial Locations (1)

200065

RECRUITING

Shanghai Tongji Hospital, Shanghai

All Listed Sponsors

lead

Aibin Liang，MD，Ph.D.

OTHER